Want to join the conversation?
Jeff Stein with Northcoast Research asks about factors contributing to the substandard performance in 4Q15 relative to the peer group. $M CFO Karen Hoguet answers by saying that part of fourth quarter relates to $M's locations being more heavily skewed towards cold weather areas and also heavy reliance on tourist markets.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?